1-3 of 3
Cibele Masotti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potential Benefits of Using the Combination of Ibet with Ibtk Chronic Lymphocytic Leukemia and Other Tumor Types

Jose Leilton C. de Carvalho, Sr., Pedro Fernandes, Fernanda de Morais Marques, Verena Pfister, Matheus Vescovi Goncalves, Ana Paula Tavares, Bruna B. Lins, Paula Asprino, Fabiana Bettoni, Cibele Masotti, Anamaria Camargo, Celso Arrais-Rodrigues, Mariane Amano
Journal: Blood
Blood (2024) 144 (Supplement 1): 6786.
https://doi.org/10.1182/blood-2024-212034
Published: 2024
Journal Articles

MAGE-C1/CT7 Inhibition Increases Myeloma Cell Line Sensitivity to Bortezomib-Induced Apoptosis: New Target for Myeloma Therapy?

Fabricio de Carvalho, Ph.D., Erico T. Costa, Anamaria A. Camargo, Juliana C. Gregorio, Cibele Masotti, Valeria C.C. Andrade, Bryan E. Strauss, Otavia L. Caballero, Djordje Atanackovic, Gisele W.B. Colleoni
Journal: Blood
Blood (2010) 116 (21): 1908.
https://doi.org/10.1182/blood.V116.21.1908.1908
Published: 2010
Journal Articles

Stable MAGEC1/CT7 Inhibition by Short Hairpin RNA (shRNA) Does Not Affect Tumor Cell Proliferation and Invasive Potential in Sko-007 Multiple Myeloma Cell Line.

Fabricio de Carvalho, Anamaria A. Camargo, Érico T. Costa, Cibele Masotti, Valéria C.C. Andrade, Bryan E. Strauss, Otávia L. Caballero, Gisele W.B. Colleoni
Journal: Blood
Blood (2009) 114 (22): 4888.
https://doi.org/10.1182/blood.V114.22.4888.4888
Published: 2009